T5	Effect 13 22	hepatitis
T7	Treatment 0 4;80 106	Drug pegvisomant and octreotide
T8	Subject 26 48	an acromegalic patient
T9	Sub-Disorder 29 40	acromegalic
T10	Drug 80 91	pegvisomant
T11	Drug 96 106	octreotide
